Antibiotics, the cornerstone of modern medicine, have been pivotal in combating infectious diseases. However, their irrational use has led to a global health crisis of antibiotic resistance. This article aims to guide medical professionals towards rational antibiotic use, promoting patient health and combating antibiotic resistance.
Antibiotic resistance occurs when bacteria change in response to the use of antibiotics, making treatments ineffective and infections harder to control. This resistance stems from overuse and misuse of antibiotics, often driven by poor prescription practices, self-medication, and non-compliance to treatment regimens.
Rational antibiotic use involves prescribing the right antibiotic, at the right dose, at the right time, and for the right duration. It necessitates a deep understanding of pharmacokinetics, pharmacodynamics, and the local antibiogram. Clinicians should also consider patient-specific factors such as age, renal function, and potential drug interactions.
Diagnostic stewardship plays a crucial role in rational antibiotic use. It involves using diagnostic tests to guide antibiotic therapy, thereby reducing unnecessary antibiotic exposure. Rapid diagnostic tests, culture and sensitivity tests, and molecular tests can help identify the pathogen and its antibiotic susceptibility, facilitating targeted therapy.
Antibiotic stewardship programs (ASPs) aim to optimize antibiotic use within healthcare settings. They involve coordinated interventions designed to improve and measure the appropriate use of antibiotics by promoting the selection of the optimal antibiotic regimen. ASPs have been shown to improve patient outcomes, reduce antibiotic resistance, and decrease healthcare costs.
Rational use of antibiotics is an urgent global necessity. By adhering to the principles of rational use, employing diagnostic stewardship, and implementing antibiotic stewardship programs, medical professionals can play a significant role in preserving the efficacy of antibiotics, promoting patient health, and combating antibiotic resistance.
1.
Research discovery halts childhood brain tumor before it forms
2.
Increased Data Support Active Monitoring for Low-Risk Prostate Cancer.
3.
'CDC Must Be Investigated'; David Lynch, Bob Uecker Die; Nasal Epinephrine Warning
4.
Increasing Access to Prostate Cancer Drugs; Reducing Toxic Emissions; FTC Files a 'Charity' Suit.
5.
Infections the Main Cause of Nonrelapse Mortality After CAR-T for Blood Cancers
1.
Beyond the Blinders: A Review of Targeted Therapeutic Strategies for Triple-Negative Breast Cancer in 2025
2.
AI-Based Cancer Follow-Up Monitoring: Transforming Survivorship Care through Intelligent Surveillance
3.
Preventing Sarcopenia During Cancer Treatment
4.
Guidance for Managing Complex Anticoagulation
5.
Unlocking the Potential of Sarclisa: A New Hope for Cancer Treatment
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Updates on Standard V/S High Risk Myeloma Treatment
2.
Navigating the Complexities of Ph Negative ALL - Part XIV
3.
Current Scenario of Blood Cancer- A Conclusion on Genomic Testing & Advancement in Diagnosis and Treatment
4.
Advances in Classification/ Risk Stratification of Plasma Cell Dyscrasias
5.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part I
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation